| __timestamp | Alnylam Pharmaceuticals, Inc. | Dr. Reddy's Laboratories Limited |
|---|---|---|
| Wednesday, January 1, 2014 | 50561000 | 132170000000 |
| Thursday, January 1, 2015 | 41097000 | 148189000000 |
| Friday, January 1, 2016 | 47159000 | 154708000000 |
| Sunday, January 1, 2017 | 89912000 | 140809000000 |
| Monday, January 1, 2018 | 74908000 | 142028000000 |
| Tuesday, January 1, 2019 | 219750000 | 153851000000 |
| Wednesday, January 1, 2020 | 492853000 | 174600000000 |
| Friday, January 1, 2021 | 844287000 | 189722000000 |
| Saturday, January 1, 2022 | 1037418000 | 214391000000 |
| Sunday, January 1, 2023 | 1828292000 | 245879000000 |
| Monday, January 1, 2024 | 2248243000 | 279164000000 |
Igniting the spark of knowledge
In the ever-evolving landscape of pharmaceuticals, Alnylam Pharmaceuticals, Inc. and Dr. Reddy's Laboratories Limited stand as titans, each with a unique trajectory. Over the past decade, Alnylam has seen a meteoric rise, with revenue surging from a modest $50 million in 2014 to an impressive $1.8 billion by 2023. This represents a staggering growth of over 3,500%, underscoring its innovative prowess in RNA interference therapeutics.
Conversely, Dr. Reddy's Laboratories, a stalwart in generic drugs, has maintained a steady revenue stream, growing from $132 billion in 2014 to $246 billion in 2023, marking an 86% increase. This stability highlights its robust market presence and strategic expansions.
While Alnylam's data for 2024 remains elusive, Dr. Reddy's projects a continued upward trend, potentially reaching $279 billion. This comparison not only showcases their financial journeys but also reflects broader industry trends.
Revenue Insights: Johnson & Johnson and Dr. Reddy's Laboratories Limited Performance Compared
Revenue Insights: AbbVie Inc. and Dr. Reddy's Laboratories Limited Performance Compared
Comparing Revenue Performance: Regeneron Pharmaceuticals, Inc. or Alnylam Pharmaceuticals, Inc.?
GSK plc or Alnylam Pharmaceuticals, Inc.: Who Leads in Yearly Revenue?
Breaking Down Revenue Trends: Alnylam Pharmaceuticals, Inc. vs Viatris Inc.
Alnylam Pharmaceuticals, Inc. and Dr. Reddy's Laboratories Limited: A Detailed Gross Profit Analysis
Alnylam Pharmaceuticals, Inc. or Geron Corporation: Who Leads in Yearly Revenue?
Alnylam Pharmaceuticals, Inc. or Novavax, Inc.: Who Leads in Yearly Revenue?
Dr. Reddy's Laboratories Limited and Bio-Techne Corporation: A Comprehensive Revenue Analysis
Dr. Reddy's Laboratories Limited vs Ascendis Pharma A/S: Annual Revenue Growth Compared
Annual Revenue Comparison: Dr. Reddy's Laboratories Limited vs Grifols, S.A.
Dr. Reddy's Laboratories Limited and HUTCHMED (China) Limited: A Comprehensive Revenue Analysis